Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies

NuSkin Enterprises logo
NuSkin EnterprisesNUS
-$3.92M-1,107%
Herbalife logo
HerbalifeHLF
$113.8M+56,800%
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
——

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation?
USANA Health Sciences (USNA) reported cash provided by (used in) operating activity, including discontinued operation of $9.76M in Q1 2026.
How has USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation decreased by 37.0% year-over-year, from $15.48M to $9.76M.
What is the long-term trend for USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation?
Over 3 years (2021 to 2024), USANA Health Sciences's cash provided by (used in) operating activity, including discontinued operation has grown at a -20.5% compound annual growth rate (CAGR), from $121.23M to $60.99M.
What does cash provided by (used in) operating activity, including discontinued operation mean?
Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.